BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 33173411)

  • 21. MicroRNA profile in stage I clear cell renal cell carcinoma predicts progression to metastatic disease.
    Moynihan MJ; Sullivan TB; Burks E; Schober J; Calabrese M; Fredrick A; Kalantzakos T; Warrick J; Canes D; Raman JD; Rieger-Christ K
    Urol Oncol; 2020 Oct; 38(10):799.e11-799.e22. PubMed ID: 32534961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An
    Fu S; Gong B; Ding Y; Zhuang C; Chen Q; Wang S; Li Z; Ma M; Liu Y; Zhang Z; Sun T
    Comb Chem High Throughput Screen; 2022; 25(13):2278-2294. PubMed ID: 35293292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRIM16 acts as an E3 ubiquitin ligase and can heterodimerize with other TRIM family members.
    Bell JL; Malyukova A; Holien JK; Koach J; Parker MW; Kavallaris M; Marshall GM; Cheung BB
    PLoS One; 2012; 7(5):e37470. PubMed ID: 22629402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Five-Gene Signature Predicts Prognosis in Patients with Kidney Renal Clear Cell Carcinoma.
    Zhan Y; Guo W; Zhang Y; Wang Q; Xu XJ; Zhu L
    Comput Math Methods Med; 2015; 2015():842784. PubMed ID: 26539246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1/2-YAP signaling.
    Yin L; Li W; Wang G; Shi H; Wang K; Yang H; Peng B
    J Exp Clin Cancer Res; 2019 Aug; 38(1):343. PubMed ID: 31391070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of enhancer RNA EMX2OS is associated with poor prognosis in kidney renal clear cell carcinoma.
    Jiang H; Chen H; Wan P; Song S; Chen N
    Aging (Albany NY); 2020 Nov; 12(24):25865-25877. PubMed ID: 33234727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma.
    Shen C; Liu J; Wang J; Zhong X; Dong D; Yang X; Wang Y
    Int Immunopharmacol; 2020 Apr; 81():106274. PubMed ID: 32044664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of BAG1 is associated with prognosis in kidney renal clear cell carcinoma based on bioinformatics.
    Wu H; Liu M; He Y; Meng G; Guo W; Guo Q
    BMC Cancer; 2021 Feb; 21(1):160. PubMed ID: 33581726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of circRNA-based ceRNA network to reveal the role of circRNAs in the progression and prognosis of metastatic clear cell renal cell carcinoma.
    Wei X; Dong Y; Chen X; Ren X; Li G; Wang Y; Wang Y; Zhang T; Wang S; Qin C; Song N
    Aging (Albany NY); 2020 Nov; 12(23):24184-24207. PubMed ID: 33223511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Novel Gene Signature of Tripartite Motif Family for Predicting the Prognosis in Kidney Renal Clear Cell Carcinoma and Its Association With Immune Cell Infiltration.
    Zheng D; Zhang Y; Xia Y; Cheng F
    Front Oncol; 2022; 12():840410. PubMed ID: 35371994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LINC00997, a novel long noncoding RNA, contributes to metastasis via regulation of S100A11 in kidney renal clear cell carcinoma.
    Chang Y; Li N; Yuan W; Wang G; Wen J
    Int J Biochem Cell Biol; 2019 Nov; 116():105590. PubMed ID: 31442606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The miR-200 family as prognostic markers in clear cell renal cell carcinoma.
    Saleeb R; Kim SS; Ding Q; Scorilas A; Lin S; Khella HW; Boulos C; Ibrahim G; Yousef GM
    Urol Oncol; 2019 Dec; 37(12):955-963. PubMed ID: 31635993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-specific hypermethylation of epigenetic biomarkers, including SFRP1, predicts for poorer survival in patients from the TCGA Kidney Renal Clear Cell Carcinoma (KIRC) project.
    Ricketts CJ; Hill VK; Linehan WM
    PLoS One; 2014; 9(1):e85621. PubMed ID: 24454902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OSkirc: a web tool for identifying prognostic biomarkers in kidney renal clear cell carcinoma.
    Xie L; Wang Q; Dang Y; Ge L; Sun X; Li N; Han Y; Yan Z; Zhang L; Li Y; Zhang H; Guo X
    Future Oncol; 2019 Sep; 15(27):3103-3110. PubMed ID: 31368353
    [No Abstract]   [Full Text] [Related]  

  • 35. Comprehensive characterization of immune- and inflammation-associated biomarkers based on multi-omics integration in kidney renal clear cell carcinoma.
    Zhao E; Li L; Zhang W; Wang W; Chan Y; You B; Li X
    J Transl Med; 2019 May; 17(1):177. PubMed ID: 31133033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of cross-omics screening for kidney clear cell renal cancer survival.
    Dimitrieva S; Schlapbach R; Rehrauer H
    Biol Direct; 2016 Dec; 11(1):68. PubMed ID: 27993167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a Set of Genes Improving Survival Prediction in Kidney Renal Clear Cell Carcinoma through Integrative Reanalysis of Transcriptomic Data.
    Ruan B; Feng X; Chen X; Dong Z; Wang Q; Xu K; Tian J; Liu J; Chen Z; Shi W; Wang M; Qian L; Ding Q
    Dis Markers; 2020; 2020():8824717. PubMed ID: 33110456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.
    Nofech-Mozes R; Khella HW; Scorilas A; Youssef L; Krylov SN; Lianidou E; Sidiropoulos KG; Gabril M; Evans A; Yousef GM
    Cancer Med; 2016 Apr; 5(4):656-64. PubMed ID: 26860079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRIM proteins in neuroblastoma.
    Xu Y; Zhang Z; Xu G
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31820796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic analysis of survival-associated alternative splicing signatures in clear cell renal cell carcinoma.
    Chen T; Zheng W; Chen J; Lin S; Zou Z; Li X; Tan Z
    J Cell Biochem; 2020 Oct; 121(10):4074-4084. PubMed ID: 31886566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.